- Previous Close
4.5200 - Open
4.4200 - Bid --
- Ask 5.0000 x --
- Day's Range
4.4200 - 4.5200 - 52 Week Range
2.7800 - 4.6000 - Volume
2,573 - Avg. Volume
1,121 - Market Cap (intraday)
3.151B - Beta (5Y Monthly) 0.36
- PE Ratio (TTM)
11.59 - EPS (TTM)
0.3900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 16, 2017
- 1y Target Est
--
Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other. It also offers educational materials for healthcare professionals and patients. The company was formerly known as Sicomed S.A. and changed its name to Zentiva S.A. in January 2006. The company was founded in 1962 and is based in Bucharest, Romania. Zentiva S.A. is a subsidiary of Zentiva Group a.s.
www.zentiva.ro1,035
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: SCD.RO
View MorePerformance Overview: SCD.RO
Trailing total returns as of 1/22/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SCD.RO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SCD.RO
View MoreValuation Measures
Market Cap
3.15B
Enterprise Value
3.15B
Trailing P/E
11.59
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.88
Price/Book (mrq)
2.26
Enterprise Value/Revenue
2.88
Enterprise Value/EBITDA
9.26
Financial Highlights
Profitability and Income Statement
Profit Margin
24.97%
Return on Assets (ttm)
11.02%
Return on Equity (ttm)
21.89%
Revenue (ttm)
1.05B
Net Income Avi to Common (ttm)
263.29M
Diluted EPS (ttm)
0.3900
Balance Sheet and Cash Flow
Total Cash (mrq)
34.88M
Total Debt/Equity (mrq)
1.55%
Levered Free Cash Flow (ttm)
-81.06M